DongKoo Bio & Pharma Co. Ltd. Long-term Investment Intensity
DongKoo Bio & Pharma Co. Ltd. long-term investment intensity. DongKoo Bio & Pharma Co. Ltd. (006620) has a Long-term Investment Intensity of 2.3% as of December 2017. Long-term investments of ₩1.76 Billion represent 2.3% of total assets of ₩75.59 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read DongKoo Bio & Pharma Co. Ltd. total liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of DongKoo Bio & Pharma Co. Ltd. (2015–2017)
Long-term investment intensity of DongKoo Bio & Pharma Co. Ltd. from 2015 to 2017. This chart shows how DongKoo Bio & Pharma Co. Ltd.'s Long-term Investment Intensity has evolved across 3 annual periods from 2015 to 2017. As of December 2017, the intensity stands at 2.3%, reflecting long-term investments of ₩1.76 Billion against total assets of ₩75.59 Billion KRW.
DongKoo Bio & Pharma Co. Ltd. Long-term Investment Intensity by Year (2015–2017)
DongKoo Bio & Pharma Co. Ltd. long-term investment intensity by year from 2015 to 2017. The table below presents the year-by-year Long-term Investment Intensity for DongKoo Bio & Pharma Co. Ltd. from 2015 to 2017, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 006620 current and non-current assets.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2017 | 2.3% | ₩1.76 Billion | ₩75.59 Billion | ▼ -1.0 pp |
| 2016 | 3.3% | ₩2.18 Billion | ₩65.31 Billion | ▼ -1.3 pp |
| 2015 | 4.6% | ₩2.82 Billion | ₩60.77 Billion | — |